ArticleScientific reports2025
ECG features improve multimodal deep learning prediction of incident T2DM in a Middle Eastern cohort.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leveraging XGBoost and explainable AI for accurate prediction of type 2 diabetes.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 2 Diabetes Mellitus (T2DM) remains a significant global health challenge, underscoring the need for early and accurate risk prediction tools to enable timely interventions. This study introduces ECG-DiaNet, a multimodal deep learning model that integrates electrocardiogram (ECG) features with established clinical risk factors (CRFs) to improve the prediction of T2DM onset. Using data from the Qatar Biobank (QBB), we compared ECG-DiaNet against unimodal models based solely on ECG or CRFs. A development cohort (n = 2043) was utilized for model training and internal validation, while a separate longitudinal cohort (n = 395) with a median five-year follow-up served as the test set. ECG-DiaNet demonstrated superior predictive performance, achieving a higher area under the receiver operating characteristic curve (AUROC) compared to the CRF-only model (0.845vs.0.8217), which was statistically significant based on the DeLong test (p < 0.001), thus highlighting the added predictive value of incorporating ECG signals. Reclassification metrics reinforced these improvements, with a significant Net Reclassification Improvement (NRI = 0.0153,p < 0.001) and Integrated Discrimination Improvement (IDI = 0.0482,p = 0.0099), confirming the enhanced risk stratification. Furthermore, stratifying participants into Low-, Medium-, and High-risk categories revealed that ECG-DiaNet achieved a higher positive predictive value (PPV) in the high-risk group compared to CRF-only models. These findings, together with the non-invasive nature and wide accessibility of ECG technology, suggest the potential of ECG-DiaNet for clinical implementation. However, further validation using larger and more diverse datasets is needed to improve generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.